Stockscreener 앱 받기
31.14
2.77%
0.84
시장 영업 전:
31.19
0.05
+0.16%
전일 마감가:
$30.30
열려 있는:
$31
하루 거래량:
736.14K
Relative Volume:
0.67
시가총액:
$3.27B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.43%
1개월 성능:
-27.55%
6개월 성능:
+1.83%
1년 성능:
+0.00%
1일 변동 폭
$29.79
$31.36
1주일 범위
$29.10
$32.20
52주 변동 폭
$12.30
$47.40
Metsera Inc Stock (MTSR) Company Profile
명칭
Metsera Inc
전화
(212) 784-6595
주소
3 WORLD TRADE CENTER, NEW YORK
MTSR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
31.14 | 3.18B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-20 | 개시 | Wells Fargo | Overweight |
| 2025-02-25 | 개시 | BofA Securities | Buy |
| 2025-02-25 | 개시 | Evercore ISI | Outperform |
| 2025-02-25 | 개시 | Guggenheim | Buy |
Metsera Inc 주식(MTSR)의 최신 뉴스
What makes Metsera Inc. stock price move sharply2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Custom watchlist performance reports with Metsera Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Statistical indicators supporting Metsera Inc.’s strength2025 Performance Recap & Fast Entry High Yield Tips - Newser
Biopharma IPO drought continues: chance of rain expected? - BioWorld MedTech
Why Metsera Inc. stock attracts strong analyst attentionEarnings Miss & Verified Short-Term Plans - thegnnews.com
How high can Metsera Inc. stock goPortfolio Gains Report & Risk Controlled Stock Pick Alerts - Newser
Price Action Confirms Reversal in Metsera Inc. TrendJuly 2025 Final Week & Reliable Intraday Trade Plans - newsyoung.net
SoftBank Group's Q2 Portfolio Changes: New Stakes in Metsera and eToro, Reduced Lemonade Holding - AInvest
SoftBank adds new Metsera, eToro stakes, pares Lemonade holding, among Q2 trades (SFTBF:Pink Limited Info) - Seeking Alpha
Chart based analysis of Metsera Inc. trendsWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Should I set a stop loss on Metsera Inc.2025 Retail Activity & Safe Capital Preservation Plans - thegnnews.com
Technical analysis overview for Metsera Inc. stockAI Volatility Forecast and Risk Monitor - Newser
Sector ETF Data Correlates with Strength in Metsera Inc.Secure Return Focused Investment Plan Released - beatles.ru
Metsera Inc (MTSR) Six Month Summary: The Bright Spot in a Quiet Biotech Year - Smartkarma
Metsera, Inc. Reports Q2 2025 Financial Progress - The Globe and Mail
Can Metsera Inc. hit a new high this monthFree Risk Adjusted Technical Entry Plan - Newser
Watch for Bullish Crossover in Metsera Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
Using portfolio simulators with Metsera Inc. includedHigh Conviction Screener with Trend Matching - Newser
What is Metsera Inc. company’s growth strategyPhenomenal trading returns - Jammu Links News
What are the latest earnings results for Metsera Inc.Unlock your portfolio’s hidden potential - Jammu Links News
Why is Metsera Inc. stock attracting strong analyst attentionUnlock expert insights for smarter investing - Jammu Links News
How volatile is Metsera Inc. stock compared to the marketBuild a diversified portfolio for risk mitigation - Jammu Links News
Is it the right time to buy Metsera Inc. stockFree Stock Market Beginners Guide - Jammu Links News
What are Metsera Inc. company’s key revenue driversUnlock powerful trading techniques - Jammu Links News
What are analysts’ price targets for Metsera Inc. in the next 12 monthsBreakthrough financial growth - Jammu Links News
What catalysts could drive Metsera Inc. stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
Is Metsera Inc. a growth stock or a value stockGet exclusive market analysis for investors - Jammu Links News
How strong is Metsera Inc. company’s balance sheetBuild wealth with high-performing stocks - Jammu Links News
Cantor Fitzgerald Forecasts Reduced Earnings for Metsera - Defense World
We're Hopeful That Metsera (NASDAQ:MTSR) Will Use Its Cash Wisely - 富途牛牛
Metsera Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingDay Trading Signals With High Precision Reviewed - metal.it
Metsera, Inc. shares fall 1.51% premarket due to lock-up agreement ending on 30-JUL-2025. - AInvest
Metsera, Inc. Lock-Up Agreement Expiration: 30-JUL-2025 - AInvest
Metsera stock rating reiterated by Cantor Fitzgerald ahead of key updates - Investing.com Nigeria
Guggenheim Maintains Metsera(MTSR.US) With Buy Rating, Maintains Target Price $62 - 富途牛牛
Metsera, Inc. Poised for Growth: Anticipated Catalysts and Clinical Trial Success Drive Buy Rating - TipRanks
Certain Options of Metsera, Inc. are subject to a Lock-Up Agreement Ending on 30-JUL-2025. - MarketScreener
Metsera reports Q2 EPS (66c), consensus (68c) - TipRanks
Metsera, Inc.: Why Shares Are on the Rise - TipRanks
Metsera Posts Narrower Q2 Loss - MarketScreener
Metsera shares tumble as quarterly loss worse than expected By Investing.com - Investing.com Canada
Metsera shares tumble as quarterly loss worse than expected - Investing.com
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress - GlobeNewswire
Metsera Obesity Drug Achieves 8.4% Weight Loss in 5 Weeks; Multiple Trial Results Coming in 2025 - Stock Titan
Recent Price Trend in Metsera Inc. (MTSR) is Your Friend, Here's Why - Yahoo Finance
Metsera Inc (MTSR) 재무 분석
Metsera Inc (MTSR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.41%
0.88%
자본화:
|
볼륨(24시간):